Venous Thromboembolism (DBCOND0000676)

Identifiers

Synonyms
Venous Thrombo-embolism / Thromboembolism, Venous / Venous Thromboembolic Event / Venous thromboembolic events / Venous thromboembolisms / Venous Thromboembolism (VTE) / VTE (Venous Thromboembolism) / VTE / Venous thromboembolism / VTES / Acute embolism and thrombosis of unspecified vein / Venous embolism (disorder) / Venous embolism / Embolism venous / Venous embolism NOS

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acetylsalicylic acid
A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events.
Betrixaban
A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients.
Dabigatran etexilate
An anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation.
Dalteparin
A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction.
Heparin
An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation.
Nadroparin
A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction.
Rivaroxaban
A factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations.
Tinzaparin
A low molecular weight heparin used for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01367184
National Inferior Vena Cava (IVC) Filter RegistryNo drug interventionsNot AvailableNot Availableterminated
NCT06025162
Evaluation of Chemical Venous Thromboembolism Prophylaxis in TraumaNot AvailableNot Availableenrolling_by_invitation
NCT04444700
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 PandemicNo drug interventionstreatment3completed
NCT06110949
Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home HospitalizationNo drug interventionsNot AvailableNot Availablerecruiting
NCT05750680
DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme InducersNo drug interventionsNot AvailableNot Availablerecruiting
NCT04359212
Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19Not AvailableNot Availablecompleted
NCT02425345
Women's Health Initiative Strong and Healthy StudyNo drug interventionspreventionNot Availableactive_not_recruiting
NCT06606275
The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF/ VTE and ESKD on DialysisNot AvailableNot Availableactive_not_recruiting
NCT06601088
Achilles Tendon Rupture - Intervention With Electrical StimulationNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03265054
Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous ThrombosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT04141228
A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the USNo drug interventionsNot AvailableNot Availablecompleted
NCT02798471
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)treatment3completed
NCT01583218
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)prevention3completed
NCT02073682
Cancer Venous Thromboembolism (VTE)treatment3completed
NCT03802929
Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous ThromboembolismNo drug interventionsNot AvailableNot Availablerecruiting
NCT02156401
VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTENo drug interventionsNot AvailableNot Availablerecruiting
NCT03521908
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood ClotNo drug interventionsNot AvailableNot Availablecompleted
NCT06443905
Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03977870
Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT03965741
Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood ThinnersNot AvailableNot Availablecompleted
NCT04243122
Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patientsprevention2completed
NCT01119274
EUropean Pharmacogenetics of AntiCoagulant Therapy - PhenprocoumonNo drug interventionsNot Available4completed
NCT06057844
Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)No drug interventionsbasic_scienceNot Availablerecruiting
NCT03081169
Timing of VTE Prophylaxis in TBIprevention4withdrawn
NCT06583330
A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer SurgerypreventionNot Availablenot_yet_recruiting
NCT05171049
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTEtreatment3recruiting
NCT05171075
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTEtreatment3recruiting
NCT05701917
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein ThrombosistreatmentNot Availablerecruiting
NCT05900388
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)Not AvailableNot Availablenot_yet_recruiting
NCT06189313
CLEANer Aspiration for Pulmonary EmbolismNo drug interventionstreatmentNot Availablerecruiting
NCT06284343
The Gynecological Cancer Associated Thrombosis (GynCAT) StudyNot AvailableNot Availablerecruiting
NCT06299111
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)No drug interventionstreatment2not_yet_recruiting
NCT06495996
The Protrieve PROTECTOR StudyNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT06616376
The Affect Of An Anti-Embolism Stocking ProtocolNo drug interventionssupportive_careNot Availablecompleted
NCT06603870
Secondary Prevention of VTE in Patients with Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosistreatment4not_yet_recruiting
NCT02017743
Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous ThromboembolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT03157843
Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine WardsNot AvailableNot Availableunknown_status
NCT01014403
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)treatment1completed
NCT01958203
Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.No drug interventionsNot AvailableNot Availablecompleted
NCT06451003
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT00182403
Fixed Dose Heparin StudyNo drug interventionstreatment3completed
NCT00201903
The Roles of Tissue Factor in Malignant GliomasNo drug interventionsNot AvailableNot Availablecompleted
NCT02480790
Venous Thromboembolic Complications in Ovarian CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02679664
StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Studyprevention2unknown_status
NCT00851864
Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based DosingNot Available4completed
NCT03870464
LIFE - Lung Cancer, Immunotherapy, Frailty, EffectNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04066764
Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filterstreatment3recruiting
NCT02160964
Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study)No drug interventionsNot AvailableNot Availableunknown_status
NCT05058521
Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)No drug interventionsNot AvailableNot Availablecompleted
NCT00333021
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patientsprevention3completed
NCT00005684
Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in ThrombosisNot AvailableNot Availablecompleted
NCT00810784
Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02219984
START-Register: Survey on Anticoagulated Patients RegisterNo drug interventionsNot AvailableNot Availablerecruiting
NCT01504087
ICU Venous Thromboembolism Incidence Study in a Chinese PopulationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05439187
Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair.No drug interventionsNot AvailableNot Availablecompleted
NCT04179487
The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01362933
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06418633
Variations in the Hemostatic System Induced by a Standardized Walking TestNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT04141254
Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.No drug interventionsother3unknown_status
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).treatment3completed
NCT04737954
A Performance Evaluation of the LumiraDx Point Of Care D-dimer AssayNo drug interventionsdiagnosticNot Availableunknown_status
NCT03935451
Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Diseaseprevention0recruiting
NCT03691753
Safety and Efficacy Study of Fitaya Vena Cava FilterNo drug interventionstreatmentNot Availableunknown_status
NCT04969653
The Incidence of Venous Thromboembolism in Atopic DermatitisNo drug interventionsNot AvailableNot Availablecompleted
NCT06556953
Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00814177
Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patientstreatment2completed
NCT00966277
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patientstreatment4completed
NCT03580577
Risk Factors and Outcomes of Acute Venous Thromboembolism in CirrhoticNo drug interventionsNot AvailableNot Availableunknown_status
NCT04940377
Effect of the Genotype on Postoperative DVTNo drug interventionsNot AvailableNot Availablecompleted
NCT03282747
Distribution of Risk Factors for Venous Thromboembolism in Blood DonorsNo drug interventionsNot AvailableNot Availablecompleted
NCT02832245
Computerized Registry of Patients With Venous Thromboembolism (RIETE)No drug interventionsNot AvailableNot Availablerecruiting
NCT01602445
Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT05881798
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01203098
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplastyprevention2completed
NCT01176305
Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005No drug interventionsNot AvailableNot Availablecompleted
NCT01598805
Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlertsNo drug interventionshealth_services_researchNot Availablecompleted
NCT00660205
Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04257305
Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical InpatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00437697
Thromboprophylaxis in Critically Ill Patientsprevention4terminated
NCT02066597
Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary EvaluationNo drug interventionstreatment2terminated
NCT00683397
Frankfurt Thrombophilia RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT05897697
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01051297
Obstructive Sleep Apnea and Venous ThromboembolismNo drug interventionsNot AvailableNot Availableterminated
NCT01467583
Fondaparinux in Critically Ill Patients With Renal Failureprevention4completed
NCT04439383
Risk Stratification for Venous Thromboembolism in Hospitalized Medical PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03266783
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolismtreatment4recruiting
NCT00329628
Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparintreatment3completed
NCT01308528
Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgeryprevention3completed
NCT02309411
EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosistreatment2completed
NCT00937911
Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremitiesprevention3completed
NCT01363193
Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientstreatmentNot Availableunknown_status
NCT04748393
Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual BleedingNo drug interventionsNot AvailableNot Availableterminated
NCT02943993
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in EuropeNot AvailableNot Availablecompleted
NCT04646993
WHITE Study: WHIch Decision After a First Venous ThromboEmbolism?No drug interventionsNot AvailableNot Availablecompleted
NCT02366871
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancyprevention2completed
NCT05229471
Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03475771
Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT02213978
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06302478
5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord DisordersNo drug interventionspreventionNot Availablerecruiting
NCT06494878
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidityprevention3not_yet_recruiting
NCT05541978
Thrombosis in Patients With Multiple Myeloma in an University Medical CenterNo drug interventionsNot AvailableNot Availablecompleted
NCT01976988
Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgeryprevention3completed
NCT04744688
Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00679588
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgeryprevention3completed
NCT01321788
Venous Thromboembolism Prophylaxis Post Cesarean SectionNot AvailableNot Availableunknown_status
NCT03660007
Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo TransferNo drug interventionsNot AvailableNot Availablecompleted
NCT03646409
Venous Thromboembolism and Bleeding Risk in Patients With Esophageal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02559856
Comparison of Bleeding Risk Between Rivaroxaban and Apixabantreatment4completed
NCT04846556
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIONo drug interventionsNot AvailableNot Availablecompleted
NCT01885585
Eliquis Regulatory Post Marketing Surveillance (rPMS)Not AvailableNot Availablecompleted
NCT04022915
PET Fibrin Imaging of DVT and PENo drug interventionsdiagnostic1recruiting
NCT01809015
Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study ProgrammeNo drug interventionsNot AvailableNot Availablecompleted
NCT01274637
PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilotprevention3completed
NCT02070237
Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxisprevention1completed
NCT02864537
Self-management of Anticoagulation TreatmentNo drug interventionstreatmentNot Availablecompleted
NCT02970032
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparinprevention0completed
NCT01205932
Dose-confirmatory Bridging Study in Total Hip Replacementprevention3completed
NCT00641732
Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacementprevention2completed
NCT00362232
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.prevention3completed
NCT02396732
Aspirin and Enoxaparin for VTE in Traumaprevention4terminated
NCT01602432
Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01083732
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of AgeNot Available2completed
NCT02704052
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Doseprevention0completed
NCT00558259
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTEprevention3completed
NCT01869075
Toronto Thromboprophylaxis Patient Safety InitiativeNo drug interventionshealth_services_researchNot Availablecompleted
NCT05878899
Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trialprevention3completed
NCT00697099
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgeryprevention3completed
NCT02379806
The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Studyprevention3completed
NCT03196349
Comparison of Oral Anticoagulants for Extended VEnous Thromboembolismtreatment4terminated
NCT00571649
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patientsprevention3completed
NCT05351749
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant UseNo drug interventionshealth_services_researchNot Availablerecruiting
NCT03141749
Venous Thromboembolism in DM1No drug interventionsNot AvailableNot Availablecompleted
NCT04768036
A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill PatientsNo drug interventionspreventionNot Availablecompleted
NCT05476913
GEKO Venous Thromboembolism Prevention StudyNo drug interventionspreventionNot Availablerecruiting
NCT02585713
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolismsupportive_care3completed
NCT00196118
Study of IVC Filter Retrieval With the GĆ¼nther Tulip Vena Cava FilterNo drug interventionsNot Available4completed
NCT04824118
Clotting Parameters After Medical AbortionNo drug interventionsNot AvailableNot Availablecompleted
NCT00063518
Monitoring Trends in Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT01608919
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer ResectionNo drug interventionsdiagnosticNot Availableterminated
NCT04736719
Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims DataNot AvailableNot Availablecompleted
NCT01357941
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)No drug interventionsNot AvailableNot Availableunknown_status
NCT02546817
Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMSNo drug interventionsNot AvailableNot Availablecompleted
NCT04374617
Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT03124017
Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical PatientsNo drug interventionspreventionNot Availablecompleted
NCT04409834
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trialprevention4completed
NCT03070834
RIPT Feasibility TrialNo drug interventionstreatmentNot Availablecompleted
NCT03563924
Allo - Cancer - ThrombosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05208216
Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical CareNo drug interventionspreventionNot Availablerecruiting
NCT00005496
Inflammation, Infection, and Future Cardiovascular RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT01847196
AngelĀ® Catheter Early Feasibility Clinical StudyNo drug interventionspreventionNot Availableterminated
NCT00354796
The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With EnoxaparinNo drug interventionsNot AvailableNot Availableunknown_status
NCT01139658
Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXANo drug interventionsNot AvailableNot Availablecompleted
NCT00501358
Sleep Apnea and Tromboembolic DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00790335
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysistreatment3completed
NCT05029063
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Cathetersprevention3recruiting
NCT03381963
Hemostatic Profiles of Endocrine Therapies for Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03977363
The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)No drug interventionsNot AvailableNot Availableterminated
NCT02707263
Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill PatientstreatmentNot Availablewithdrawn
NCT04295486
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplastyprevention2recruiting
NCT05891886
Supplemental Oxygen in Pulmonary Embolism (SO-PE)No drug interventionsother0recruiting
NCT05735639
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)prevention4recruiting
NCT01225822
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgeryprevention2completed
NCT01401725
Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical PatientsNo drug interventionspreventionNot Availablecompleted
NCT00244725
Odiparcil For The Prevention Of Venous Thromboembolismprevention2completed
NCT05819125
Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With EnoxaparinNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02935530
Thromboprophylaxis After Surgery for Gynecologic Malignancy in Chinatreatment3completed
NCT02596230
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT05209048
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)No drug interventionsNot AvailableNot Availablecompleted
NCT00119457
Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)prevention2completed
NCT00149357
Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)No drug interventionsNot AvailableNot Availableterminated
NCT02420626
Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter SystemNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00470626
Celect Vena Cava Filter Clinical TrialNo drug interventionstreatmentNot Availablecompleted
NCT02486666
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Doseother3unknown_status
NCT05794165
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous ThromboembolismNo drug interventionstreatment2enrolling_by_invitation
NCT06581965
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenTNo drug interventionsprevention4not_yet_recruiting
NCT03212365
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive SurgeryNo drug interventionsother2completed
NCT02774265
A Different Approach to Preventing Thrombosisprevention3completed
NCT04963374
the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory InpatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03244020
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncologyprevention4enrolling_by_invitation
NCT04736420
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims DataNot AvailableNot Availablecompleted
NCT03240120
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolismtreatment3unknown_status
NCT03134820
Time of Treatment With LMWH in Cancer Patients With Thromboembolic DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00332020
Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacementtreatment3completed
NCT01158482
Filter Initial & Long Term Evaluation After Placement and Retrieval RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03083782
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimusbasic_science1completed
NCT00694382
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapyprevention3completed
NCT02303431
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Studybasic_science1completed
NCT03781531
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous ThromboembolismNo drug interventionsNot AvailableNot Availablerecruiting
NCT03988231
Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Studyprevention4withdrawn
NCT01744431
Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06350331
Smart Technology Facilitated Patient-centered Venous Thromboembolism ManagementNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT06168331
Chinese Community Inpatient ThromboembolismNo drug interventionsNot AvailableNot Availablerecruiting
NCT06353373
Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention StrategiesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01345773
Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04625673
OsciPulse Device for the Prevention of VTENo drug interventionsotherNot Availablecompleted
NCT04319627
Statins for Venous Event Reduction in Patients With Venous Thromboembolismtreatment3recruiting
NCT03054727
Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )No drug interventionsNot AvailableNot Availablecompleted
NCT00856076
Venous Thromboembolism in Pregnancy StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04999176
Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparinprevention3unknown_status
NCT05939960
Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06129760
Glioblastoma Remote Monitoring and Care - Research ProtocolNo drug interventionstreatmentNot Availablerecruiting
NCT06020560
Study of Low Molecular Weight Heparinstreatment4recruiting
NCT02223260
Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of AgeNot Available2completed
NCT02155491
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic EventsNo drug interventionsNot AvailableNot Availablecompleted
NCT05536791
A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotNot AvailableNot Availablewithdrawn
NCT05795062
Treatment Patterns Among Patients With Venous Thromboembolism in the United StatesNot AvailableNot Availablecompleted
NCT03835780
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02945280
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosistreatment4terminated
NCT00952380
Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patientstreatment2completed
NCT05104229
SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgeryprevention3withdrawn
NCT05108389
Sonoclot to Evaluate Thrombotic Risk in Proteinuric PregnancyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03158792
Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Functionprevention4completed
NCT00437892
Statins to Reduce D-dimer Levels in Patients With Venous Thrombosistreatment2terminated
NCT02744092
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancertreatmentNot Availablecompleted
NCT04569344
COVID-19 and Venous Thromboembolism RiskNo drug interventionsNot AvailableNot Availablecompleted
NCT02901067
STAT-STatin and Aspirin in Traumatreatment2terminated
NCT00402467
An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Studyprevention2completed
NCT02739867
Tumor-educated Platelets in Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT03277001
Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPDtreatmentNot Availableunknown_status
NCT04444804
Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in GermanyNot AvailableNot Availablecompleted
NCT03259204
Swedish Multicenter Trial of Outpatient Prevention of Leg ClotsNo drug interventionspreventionNot Availablerecruiting
NCT02687204
Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patientsprevention1completed
NCT02503904
Tumescent Antibiotic Delivery for Prevention of Surgical Site Infectionprevention2 / 3unknown_status
NCT00709904
Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgeryprevention3completed
NCT02828904
RIVET - Retrospective Cohort Study on the Risk of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT05185804
Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19treatment3completed
NCT03214172
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With RivaroxabanNot AvailableNot Availablecompleted
NCT05195372
Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT02950168
Edoxaban Management in Diagnostic and Therapeutic ProceduresNo drug interventionsNot AvailableNot Availablecompleted
NCT05264168
Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims DataNot AvailableNot Availablecompleted
NCT03477968
ThRombosis ExclUsion STudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06393868
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolismtreatment3not_yet_recruiting
NCT02464969
Apixaban for the Acute Treatment of Venous Thromboembolism in Childrentreatment4completed
NCT04169269
Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxabanprevention4unknown_status
NCT01573169
PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patientsprevention3terminated
NCT05819112
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical IllnessNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02248610
Follow-up in Rivaroxaban Patients in Setting of ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT01446510
Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05382481
Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous ThromboembolismNo drug interventionsotherNot Availablerecruiting
NCT04992195
Impact of COVID-19 Vaccines on Cerebrovascular HealthNo drug interventionsNot AvailableNot Availablerecruiting
NCT04574895
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) EventsNo drug interventionsscreeningNot Availablecompleted
NCT02856295
anti10a Levels in Women Treated With LMWH in the Postpartum Periodprevention4completed
NCT06218095
Pregnancy and Postpartum Period Venous Thromboembolism and SimulationNo drug interventionsotherNot Availableactive_not_recruiting
NCT00831714
Xarelto for VTE Prophylaxis After Hip or Knee ArthroplastyNot AvailableNot Availablecompleted
NCT00523614
Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT04947514
Use of Tranexamic Acid in Reduction Mammoplastyprevention4completed
NCT05347550
Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical PatientsNo drug interventionspreventionNot Availablerecruiting
NCT00631423
Evaluation of Patients With Vena Cava Inferior ThrombosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03068923
Thrombosis Outcomes in Pediatric Venous ThromboembolismNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04272723
Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine PhysiciansNo drug interventionsNot AvailableNot Availablecompleted
NCT04735523
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims DataNot AvailableNot Availablecompleted
NCT01304108
Improving Venous Thromboembolism ProphylaxisNo drug interventionshealth_services_research4completed
NCT01720108
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplastyprevention3completed
NCT00925808
Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) ScansNo drug interventionsNot AvailableNot Availableunknown_status
NCT03581708
Venous Thromboembolism in Advanced Lung CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05378308
NOACs Use in AF or VTE (SUNSHINE Registry)No drug interventionsNot AvailableNot Availablerecruiting
NCT04263038
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolismtreatment4recruiting
NCT06382038
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary ThromboembolismNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05920343
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapyprevention2 / 3not_yet_recruiting
NCT00531843
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patientsprevention2 / 3completed
NCT01029743
Xarelto Regulatory Post-Marketing SurveillanceNot AvailableNot Availablecompleted
NCT04041843
Oral Anticoagulant Apixaban for Treatment of Venous Thromboembolismtreatment2completed
NCT02943343
The China Pulmonary Thromboembolism Registry StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00005543
Genetic Epidemiology of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT02969343
Patient Safety Learning Laboratory: Making Acute Care More Patient-CenteredNo drug interventionshealth_services_researchNot Availablecompleted
NCT01046903
An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With FragminĀ®Not AvailableNot Availablecompleted
NCT04168203
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolismtreatment4active_not_recruiting
NCT00981903
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancerprevention2terminated
NCT03919890
A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult VolunteersNo drug interventionstreatment1completed
NCT01984190
Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.TĀ® Mobile Compression Device for Thrombosis Prevention in Hip and Knee ArthroplastyNo drug interventionsNot AvailableNot Availablecompleted
NCT01403090
Safety Study of the Angelā„¢ Catheter in Subjects With Risk of Pulmonary EmbolismNo drug interventionsprevention1completed
NCT01835990
Feasibility Study of Geko vs. IPCs in TraumaNo drug interventionsprevention2completed
NCT06257290
The Role of Platelet TLRs in Platelet Activation During VTENo drug interventionsNot AvailableNot Availablerecruiting
NCT03535090
Coagulation After Intravenous Methylprednisolone AdministrationNot AvailableNot Availablecompleted
NCT05860790
Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following NeurosurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT02898090
Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant PrescriptionsNo drug interventionsNot AvailableNot Availablecompleted
NCT04477564
Clonal Hematopoiesis of Indeterminate Potential in Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT01234064
Graduated Compression Stockings (GCS) Pilot SubstudyNo drug interventionstreatment3completed
NCT05964621
Venous Thromboembolism in Primary Pancreatic Tumour ResectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05306821
Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement StudyNo drug interventionspreventionNot Availablerecruiting
NCT00182221
Safety of a Diagnostic Strategy With D-Dimer Testing for PENo drug interventionsdiagnostic3completed
NCT05189002
A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacementtreatment2unknown_status
NCT01181102
A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplastyprevention3completed
NCT04662684
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trialprevention3completed
NCT02079584
Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific AnticoagulantNo drug interventionsNot AvailableNot Availablecompleted
NCT06302179
Risk Factors of Venous Thromboembolism After Colorectal Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT04479579
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgeryprevention4completed
NCT02833987
Direct Oral Anticoagulants and Venous ThromboembolismNot AvailableNot Availablecompleted
NCT04257487
Sulodexide, VESSELĀ®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)prevention3recruiting
NCT04920487
Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic EpisodeNo drug interventionsNot AvailableNot Availablecompleted
NCT00917254
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgeryprevention2 / 3completed
NCT04128254
A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)treatment4unknown_status
NCT02066454
Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDstreatment3unknown_status
NCT06278051
An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous ThromboembolismNot AvailableNot Availablerecruiting
NCT02877251
Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic DiseaseNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02898051
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous ThromboembolismNo drug interventionsNot AvailableNot Availableunknown_status
NCT00005351
Incidence and Outcomes of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT01050153
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following TraumapreventionNot Availablecompleted
NCT00077753
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilizationprevention4completed
NCT01524653
Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)prevention2completed
NCT02201277
ODEN Trial: Option vs. Denali IVC FiltersNo drug interventionstreatmentNot Availableterminated
NCT00222677
Aspirin for the Prevention of Recurrent Venous Thromboembolismtreatment2 / 3unknown_status
NCT04400877
Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 PandemicNo drug interventionsNot AvailableNot Availablecompleted
NCT01895777
Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)treatment3completed
NCT04663477
Development and Validation of the Patient-completed Caprini Risk ScoreNo drug interventionsNot AvailableNot Availableunknown_status
NCT00361647
Screening for Occult Malignancy in Idiopathic Venous ThromboembolismNo drug interventionsdiagnosticNot Availablecompleted
NCT00978445
Remote Home Prothrombin Time (PT)/International Normalized Ratio (INR) Monitoring and Patient Management SystemNo drug interventionstreatmentNot Availablecompleted
NCT01153698
Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement SurgeryNot AvailableNot Availableterminated
NCT00398905
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacementprevention2completed
NCT01653405
Improving Anticoagulation Control in VISN 1No drug interventionshealth_services_researchNot Availablecompleted
NCT01267305
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgerypreventionNot Availablecompleted
NCT03041805
Caprini Score in Venous Surgery: a Prospective Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00338897
Dose Ranging Study in Elective Total Hip Replacement Surgeryprevention2 / 3completed
NCT00714597
Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobilityprevention3terminated
NCT06445283
Determination of Venous Thromboembolism Risk and Nursing Practices in Patients Hospitalized in Medical ServicesNo drug interventionsNot AvailableNot Availablecompleted
NCT01857583
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbsprevention3completed
NCT00912483
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patientsprevention3withdrawn
NCT01713361
Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS-FXIRx in Total Knee Arthroplastyprevention2completed
NCT01119261
EUropean Pharmacogenetics of AntiCoagulant Therapy - AcenocoumarolNo drug interventionsNot Available4completed
NCT00445328
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patientsprevention4terminated
NCT03535428
Venous Thrombo-embolic Complication prƩvention in Pelvic SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT03812328
Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacementprevention2completed
NCT00902928
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgeryprevention2 / 3completed
NCT03309293
Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral ContraceptivesNo drug interventionspreventionNot Availableunknown_status
NCT02301793
Educating Nurses About Venous Thromboembolism (VTE) PreventionNo drug interventionspreventionNot Availablecompleted
NCT05226793
Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01524393
Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro FertilizationNo drug interventionsNot AvailableNot Availablecompleted
NCT02895971
Incidence of Venous Thromboembolism and Professional Practices in Brest AreaNo drug interventionsNot AvailableNot Availablecompleted
NCT03405571
Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.No drug interventionsNot AvailableNot Availableunknown_status
NCT01559207
Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT01916707
Weight Based Enoxaparin in Trauma Patientsprevention4unknown_status
NCT02334007
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgeryprevention1 / 2completed
NCT05461807
An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)Not AvailableNot Availablecompleted
NCT00634907
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)No drug interventionstreatmentNot Availablecompleted
NCT05628207
Evaluation of the SCALED (SCaling AcceptabLE cDs)No drug interventionsNot AvailableNot Availablerecruiting
NCT00303407
Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative CareNot AvailableNot Availableterminated
NCT02095509
Pharmacokinetics of Enoxaparin in Intensive Care Patientsprevention4completed
NCT04393909
Improving Safety of Diagnosis and Therapy in the Inpatient SettingNo drug interventionspreventionNot Availablecompleted
NCT04600609
Examining the Experiences of Children With Blood DisordersNo drug interventionsNot AvailableNot Availablerecruiting
NCT03516656
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparinprevention0completed
NCT01431456
Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgeryprevention3completed
NCT01561885
Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysNo drug interventionshealth_services_researchNot Availablecompleted
NCT02746185
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxabantreatment3completed
NCT03949985
Longitudinal Hemostatic Profile After Stopping Estroprogestative ContraceptivesNo drug interventionsNot AvailableNot Availablecompleted
NCT00007085
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)No drug interventionsdiagnosticNot Availablecompleted
NCT00844415
Safety and Tolerability of Dabigatran Etexilate in Adolescentstreatment2completed
NCT00876915
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patientsprevention3terminated
NCT00005515
Mutations, Hormone Therapy (HRT) and Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT06166537
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological ThromboprophylaxisNo drug interventionspreventionNot Availablerecruiting
NCT04710732
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.prevention4unknown_status
NCT06087952
Leiden Thrombosis Recurrence Risk PreventionNo drug interventionsotherNot Availablerecruiting
NCT01119300
EUropean Pharmacogenetics of AntiCoagulant Therapy - WarfarinNo drug interventionsNot Available4completed
NCT00755300
Total Knee Arthroplasty And Thromboembolism: A Comparison Between Two Surgical TechniquesNo drug interventionsNot AvailableNot Availablecompleted
NCT04106700
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDstreatment2terminated
NCT03025100
VTE Prophylaxis Guidelines in Hospitalized EldersNo drug interventionsNot AvailableNot Availablecompleted
NCT06523959
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trialtreatment4recruiting
NCT02735759
Detecting Circulating Emboli in Patients with Acute Venous ThromboembolismNo drug interventionsscreeningNot Availablewithdrawn
NCT03297359
WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolismtreatment2terminated
NCT00604370
Retrospective Study to Review Patients at Risk for VTE at Hospital DischargeNo drug interventionsNot AvailableNot Availablecompleted
NCT00830570
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice SettingsNo drug interventionsNot AvailableNot Availablecompleted
NCT06452342
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Studytreatment4not_yet_recruiting
NCT05498142
Predicting the Risk of Venous Thromboembolism in Critically Ill PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02952599
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)Not AvailableNot Availablecompleted
NCT00789399
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxistreatmentNot Availableterminated
NCT02271399
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplastyprevention2completed
NCT03045406
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancertreatment3unknown_status
NCT03678506
Apixaban for Extended Anticoagulation (APIDULCIS)prevention4terminated
NCT03339349
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Traumaother2completed
NCT01277536
Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in SwitzerlandNo drug interventionsNot AvailableNot Availablecompleted
NCT00788736
Predicting Bleeding Risk on Anticoagulant Therapy for Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT04865913
Venous Thrombosis Virtual Surveillance in COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT03200613
Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injuryprevention2terminated
NCT04195113
Perioperative Anticoagulant Use for Surgery Evaluation Emergency RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT04504318
Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCTprevention1 / 2completed
NCT05926518
Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05887518
The Effect of Sock Developed With Wearable Technology for TUR Surgery Patients on Hypothermia and Venous ThromboembolismNo drug interventionspreventionNot Availablewithdrawn
NCT01181141
Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgeryprevention3completed
NCT03115541
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal ResectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00428441
D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous ThromboembolismtreatmentNot Availableterminated
NCT06194617
Rivaroxaban in Elderly Chinese Venous Thromboembolism PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01088334
Mortality Due to Malignancy in Patients With Idiopathic Venous ThromboembolismNo drug interventionsNot AvailableNot Availableterminated
NCT02912234
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participantsbasic_science1completed
NCT05058924
Low Molecular Weight hEparin vs. Aspirin Post-partumpreventionNot Availablerecruiting
NCT00718224
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgeryprevention3completed
NCT03799016
An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in TaiwanNo drug interventionsNot AvailableNot Availablecompleted
NCT04766216
Warfarin Patient Self-management Implementation in the US Healthcare SystemNo drug interventionstreatmentNot Availablerecruiting
NCT02197416
Safety of Dabigatran Etexilate in Blood Clot Prevention in Childrenprevention3completed
NCT00476216
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancertreatment1completed
NCT02870296
Anticoagulation Medical HomeNo drug interventionshealth_services_researchNot Availablecompleted
NCT00456196
Epidemiology of Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT00493896
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patientsprevention3terminated
NCT00973596
The Swiss Venous Thromboembolism Cohort 65+No drug interventionsNot AvailableNot Availablecompleted
NCT01781858
Study on the Clinical Course Of Pulmonary EmbolismNo drug interventionsNot AvailableNot Availablecompleted
NCT03404635
Monotherapy Anticoagulation To Expedite Home Treatment of Venous ThromboembolismNot AvailableNot Availablecompleted
NCT02170935
Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgerytreatment2completed
NCT05378035
DOAC in Chinese Patients With Atrial FibrillationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00942435
A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgeryprevention3completed
NCT03251963
Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patientsother2completed
NCT00853463
Discharge ALERT: Quality Improvement InitiativeNo drug interventionspreventionNot Availablecompleted
NCT05022563
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in KoreaNot AvailableNot Availablecompleted
NCT00396786
Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacementprevention2completed
NCT01140386
Prevalence and Risk Factors of Venous Thromboembolism in Hospitalized Pediatric PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01851239
Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University HospitalNo drug interventionsNot AvailableNot Availablecompleted
NCT04352439
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapyprevention4completed
NCT02064439
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)prevention3completed
NCT01004939
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous ThromboembolismNot AvailableNot Availablecompleted
NCT01803022
Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01130025
Long-Term InnohepĀ® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancertreatment3completed
NCT00439725
Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Studyprevention3completed
NCT06372730
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)No drug interventionspreventionNot Availablenot_yet_recruiting
NCT06454630
A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participantstreatment2recruiting
NCT00773448
Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismNo drug interventionsscreeningNot Availablecompleted
NCT00774748
Once Weekly Subcutaneous Ports for the Administration of AnticoagulantsNo drug interventionssupportive_careNot Availablecompleted
NCT04130048
Thrombus Elastography in Venous Thrombo-Embolism.No drug interventionsNot AvailableNot Availableunknown_status
NCT01817257
Anticoagulation Length in Cancer Associated Thrombosissupportive_care2terminated
NCT02836457
ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTENo drug interventionsNot AvailableNot Availablecompleted
NCT02829957
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleedingtreatment2 / 3completed
NCT03031457
Microsurgical Breast Reconstruction & VTENo drug interventionsNot AvailableNot Availablecompleted
NCT03728166
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)No drug interventionspreventionNot Availablerecruiting
NCT03292666
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism StudyNot AvailableNot Availablecompleted
NCT05487066
Efficacy of ICU-VTE Scale in ICU PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT06073366
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00676065
Long-term Active Surveillance Study for Oral Contraceptives (LASS)No drug interventionsNot AvailableNot Availablecompleted
NCT02795065
Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU PatientstreatmentNot Availablecompleted
NCT02558465
Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)Not AvailableNot Availablecompleted
NCT02048865
Apixaban for the Prevention of Venous Thromboembolism in Cancer Patientsprevention2completed
NCT01348074
Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K AntagonistNo drug interventionstreatment2completed
NCT03044574
Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous ThromboembolismNo drug interventionspreventionNot Availablecompleted
NCT01773174
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Agetreatment2withdrawn
NCT03087474
Treatment of Venous Thromboembolism in Real-Life PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00913120
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgeryprevention2 / 3completed
NCT00937820
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolismprevention3completed
NCT05515120
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Eventstreatment2 / 3completed
NCT00689520
Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosistreatment4completed
NCT00541320
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)prevention2withdrawn
NCT03426982
Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoringsupportive_care4unknown_status
NCT02412982
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patientsprevention4completed
NCT03099031
Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)Not AvailableNot Availablecompleted
NCT00219973
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)prevention3completed
NCT02297373
Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)No drug interventionsNot AvailableNot Availablecompleted
NCT02185027
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral AnticoagulantsNo drug interventionsNot AvailableNot Availablecompleted
NCT05449327
Xarelto for Thromboprophylaxis After Total Hip and Total Knee ArthroplastypreventionNot Availablerecruiting
NCT04068727
LEAVE Safe With DOACsNo drug interventionshealth_services_researchNot Availablecompleted
NCT01195727
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheterother1terminated
NCT00135876
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patientsprevention3completed
NCT01317160
Compression Treatment Effects on Complications and Healing of Achilles Tendon RuptureNo drug interventionspreventionNot Availablecompleted
NCT00721760
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgeryprevention3completed
NCT04153760
Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidityprevention0completed
NCT06480994
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision SupportNo drug interventionsNot AvailableNot Availablerecruiting
NCT06440694
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)treatment3not_yet_recruiting
NCT06258694
Venous Thrombo-Embolism Imaging Database (VTE-ID)No drug interventionsNot AvailableNot Availablecompleted
NCT00361894
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.prevention3completed
NCT02583191
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patientstreatment3terminated
NCT03006562
PREvention of VENous ThromboEmbolism Following Radical Prostatectomyprevention4terminated
NCT04335162
Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)No drug interventionsNot AvailableNot Availableunknown_status
NCT03090880
Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)prevention3terminated
NCT06416280
Inter-observer Reliability of the TRiP(Cast) Score in Patients With Trauma to a Lower Limb Requiring ImmobilisationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00192829
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT04064489
Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.No drug interventionspreventionNot Availablecompleted
NCT04349189
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02411292
Enoxaparin Metabolism in Reconstructive Surgery Patientsother2completed
NCT01890044
Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma PatientsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06350344
Smart Technology Facilitated Patient-centered Venous Thromboembolism ManagementNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT05756244
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolismNo drug interventionsNot AvailableNot Availablerecruiting
NCT05966740
A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotNo drug interventionsNot AvailableNot Availablerecruiting
NCT04075240
VTE Prevention Following Total Hip and Knee Arthroplastyprevention3recruiting
NCT06195540
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTingprevention3recruiting
NCT00934167
Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patientsprevention2 / 3unknown_status
NCT02904967
Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole GenomeNo drug interventionspreventionNot Availablecompleted
NCT05066867
LMWH Compliance in PregnancyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05143567
Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic ComplicationsNo drug interventionsotherNot Availablecompleted
NCT01181167
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplastyprevention3completed
NCT03988101
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Eventtreatment4unknown_status
NCT02170701
BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgerytreatment2completed
NCT04539301
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux LevelsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02900404
Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision AlgorithmNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00395772
Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosistreatment2completed
NCT01203072
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplastyprevention2completed
NCT01206972
Dose-confirmatory Bridging Study in Total Knee Replacementprevention3completed
NCT02661568
Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)No drug interventionsNot AvailableNot Availablecompleted
NCT02958969
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myelomaprevention4completed
NCT01164046
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolismtreatment3terminated
NCT01448746
Optimal Prophylactic Method of Venous Thromboembolism (VTE)prevention3unknown_status
NCT02911012
Multiple Algorithms System Of All Scores in Embolism (MOSE)No drug interventionsNot AvailableNot Availableunknown_status
NCT02474212
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgeryprevention4completed
NCT03195010
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced ThrombocytopeniaNo drug interventionssupportive_care2terminated
NCT02443610
Haemorrhages and Thromboembolic Venous Disease of the PostpartumNo drug interventionsNot AvailableNot Availablecompleted
NCT04211181
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous ThromboembolismNo drug interventionspreventionNot Availablerecruiting
NCT02713581
IgG Dependent Monocyte Activation in Proximal Venous ThromboembolismNo drug interventionsNot AvailableNot Availablecompleted
NCT04157881
A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteersprevention4completed
NCT01629381
Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopyprevention2completed
NCT02402881
Education Bundle to Decrease Patient Refusal of VTE ProphylaxisNo drug interventionstreatmentNot Availablecompleted
NCT02331095
Statin Use in Patients With Acute VTEtreatment0terminated
NCT00954395
DULCIS (D-dimer and ULtrasonography in Combination Italian Study)No drug interventionsNot AvailableNot Availablecompleted
NCT01372514
Institutional Registry of Thromboembolic DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05033314
THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)prevention3recruiting
NCT00000614
Prevention of Recurrent Venous Thromboembolism (PREVENT)prevention3completed
NCT01210755
Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thromboticsbasic_science4completed
NCT02978950
SToP: Venous Thromboembolism Screening in the Trauma PopulationNo drug interventionsdiagnosticNot Availableunknown_status
NCT01028950
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illnessprevention3completed
NCT00657150
Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplastyprevention3completed
NCT02186223
The AngelĀ® Catheter Pivotal Clinical TrialNo drug interventionspreventionNot Availablecompleted
NCT06580223
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myelomaprevention3not_yet_recruiting
NCT03243708
Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical PatientsNo drug interventionspreventionNot Availablecompleted
NCT05683808
Venous Thromboembolism Prevention in Outpatients With Gliomasupportive_care2not_yet_recruiting
NCT05240508
Platelet FcGammaRIIa and Risk of Venous Thromboembolism in CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05618808
A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participantstreatment2completed
NCT00331838
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgeryprevention2completed
NCT03285438
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.No drug interventionsprevention3completed
NCT01972243
Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction ModelNo drug interventionsNot AvailableNot Availablecompleted
NCT02234843
EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosistreatment3completed
NCT03616366
The Mechanism and Prognosis of Pulmonary Circulation DysfunctionNo drug interventionsNot AvailableNot Availableunknown_status
NCT01864447
Exercise Training After an Acute Blood ClotNo drug interventionstreatmentNot Availablecompleted